Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

183
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
183
Drug Therapy01:28

Drug Therapy

34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
34
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

421
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
421
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
559
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

3.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes for Emergency Department Presentations of Sepsis Managed on a Clinical Pathway: A Systematic Review and Meta-Analysis.

Healthcare (Basel, Switzerland)·2026
Same author

Acute Suspected Stroke Clinical Pathway Use in Tasmanian Emergency Departments: A Retrospective Study.

Emergency medicine Australasia : EMA·2026
Same author

Exploring Learning Engagement in Rural and Urban Nursing Placements: A Five-Year Mixed-Methods Study.

International journal of environmental research and public health·2026
Same author

The Financial Costs and Effects on the Well-Being of Nursing Students' Professional Experience Placements: A Cross-Sectional Comparative Study of Urban and Rural Experiences.

International journal of environmental research and public health·2025
Same author

Improving oral health service delivery: the patient perspective.

Primary health care research & development·2025
Same author

Junior Doctors' Experiences of Workplace Bullying, Harassment and Discrimination in Australia and Aotearoa New Zealand-A Scoping Review.

ANZ journal of surgery·2025

Related Experiment Video

Updated: May 26, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.0K

Using Healthcare Redesign to Identify Medication Management Issues in Parkinson's Disease.

Susan Williams1, Marissa A Iannuzzi1, Sarah J Prior2

  • 1New South Wales Health, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.

Pharmacy (Basel, Switzerland)
|February 25, 2025
PubMed
Summary

Hospital medication management for Parkinson's disease (PD) patients needs improvement. Key issues include patient identification, medication timing, and staff knowledge, impacting patient experience and health outcomes.

Keywords:
Parkinson diseaseParkinson’s diseasehealthcare redesignmedicationmedication errorspatient experiencequality and safety

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.2K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.6K

Related Experiment Videos

Last Updated: May 26, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.0K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.2K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.6K

Area of Science:

  • Healthcare Improvement
  • Health Services Research
  • Patient Experience

Background:

  • Parkinson's disease (PD) management relies heavily on pharmacotherapy.
  • Patients with PD often have complex medication needs that are poorly managed during hospital stays.
  • Hospital admissions present challenges for maintaining optimal medication regimens for PD patients.

Purpose of the Study:

  • To identify issues impacting medication management for PD patients during hospital admission.
  • To understand the experiences of patients and healthcare staff regarding PD medication management.
  • To inform healthcare redesign for improved medication practices in a tertiary hospital.

Main Methods:

  • Utilized a mixed-methods approach within a healthcare redesign framework.
  • Analyzed organizational data (n=222) including patient identification, medication reviews, and administration timing.
  • Conducted online surveys and interviews with healthcare staff (n=81) and patients (n=18, n=16).

Main Results:

  • Organizational data revealed issues with PD patient identification, medication reviews, prescribing, and administration timing.
  • Staff surveys indicated a lack of PD medication knowledge and poor patient identification affected patient experience.
  • Patient feedback suggested improvements in confidence regarding medication management and administration timing.

Conclusions:

  • Ineffective hospital medication management for PD patients negatively impacts patient experience.
  • Improvements in PD medication management are crucial for better patient outcomes and health service efficiency.